About Ensysce
Research Programs
Intellectual Property
Announcements
Related Studies
Contact Us
Recent Announcements
8th Annual Nanotechnology and Sustainability Venture Forum
Ensysce Biosciences to present at 8th Annual Nanotechnology and Sustainability Venture Forum
READ MORE
"Nanotechnology: The Opportunity for Cancer Treatment"
Bob Gower to give Keynote Speech at Chemical Heritage Society's Joseph Priestly Society Symposium.
READ MORE
Ensysce Biosciences Inc. Appoints Dr. D. Lynn Kirkpatrick as President and CEO.
READ MORE
HomeAbout EnsysceContact Us
 
Recent Announcements
Presentation Nov. 10, 2009
READ FULL ARTICLE
Safety of single-walled carbon nanotubes for delivery of siRNA
D. Lynn Kirkpatrick, Geoffrey Bartholomeusz, Michelle Weiss, Dmitri Tsyboulski, Saunab Ghosh, Anton Naumov, R. Bruce Weisman.
Ensysce Biosciences. Inc., Houston, TX, UT MD Anderson Cancer Center, Houston, TX, Rice University, Houston, TX
READ FULL ARTICLE
8th Annual Nanotechnology and Sustainability Venture Forum
Ensysce Biosciences to present at 8th Annual Nanotechnology and Sustainability Venture Forum
READ FULL ARTICLE
Jan 8, 2009 : "Nanotechnology: The Opportunity for Cancer Treatment"
Bob Gower to give Keynote Speech at Chemical Heritage Society's Joseph Priestly Society Symposium.
READ FULL ARTICLE
Jan 5, 2009: Ensysce Biosciences Inc. Appoints Dr. D. Lynn Kirkpatrick as President and CEO.
Houston, TX, Jan 5, 2009 - Ensysce Biosciences Inc. announced today the appointment of Dr. Lynn Kirkpatrick as President and CEO. Dr. Kirkpatrick has an extensive background in targeted small molecule cancer drug development, and has brought three agents from bench to bedside.
READ FULL ARTICLE
Copyright © 2008 Ensysce Biosciences Inc. All Rights Reserved
Home|About Ensysce|Contact Us
Research Programs|Intellectual Property|Announcements|Related Studies